499 related articles for article (PubMed ID: 17703127)
1. ACE2: a new target for cardiovascular disease therapeutics.
Raizada MK; Ferreira AJ
J Cardiovasc Pharmacol; 2007 Aug; 50(2):112-9. PubMed ID: 17703127
[TBL] [Abstract][Full Text] [Related]
2. [The importance of ACE2 in regulating the cardiovascular system].
Raz A; Gamliel-Lazarovich A; Bogner I; Strigevsky A; Keidar S
Harefuah; 2007 Sep; 146(9):703-6, 733. PubMed ID: 17969309
[TBL] [Abstract][Full Text] [Related]
3. [Effects of ACE2-Ang 1-7-Mas axis on blood vessel].
Liu CQ; Huang Y; Lu LM
Sheng Li Ke Xue Jin Zhan; 2007 Jan; 38(1):43-8. PubMed ID: 17438952
[TBL] [Abstract][Full Text] [Related]
4. Role of the ACE2/Angiotensin 1-7 Axis of the Renin-Angiotensin System in Heart Failure.
Patel VB; Zhong JC; Grant MB; Oudit GY
Circ Res; 2016 Apr; 118(8):1313-26. PubMed ID: 27081112
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin-converting enzyme 2, angiotensin-(1-7) and Mas: new players of the renin-angiotensin system.
Santos RA; Ferreira AJ; Verano-Braga T; Bader M
J Endocrinol; 2013 Feb; 216(2):R1-R17. PubMed ID: 23092879
[TBL] [Abstract][Full Text] [Related]
6. ACE2 and vasoactive peptides: novel players in cardiovascular/renal remodeling and hypertension.
Mendoza-Torres E; Oyarzún A; Mondaca-Ruff D; Azocar A; Castro PF; Jalil JE; Chiong M; Lavandero S; Ocaranza MP
Ther Adv Cardiovasc Dis; 2015 Aug; 9(4):217-37. PubMed ID: 26275770
[TBL] [Abstract][Full Text] [Related]
7. ACE2 of the heart: From angiotensin I to angiotensin (1-7).
Keidar S; Kaplan M; Gamliel-Lazarovich A
Cardiovasc Res; 2007 Feb; 73(3):463-9. PubMed ID: 17049503
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human angiotensin-converting enzyme 2 as a new renin-angiotensin system peptidase for heart failure therapy.
Oudit GY; Penninger JM
Curr Heart Fail Rep; 2011 Sep; 8(3):176-83. PubMed ID: 21611889
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular actions of angiotensin-(1-7).
Ferreira AJ; Santos RA
Braz J Med Biol Res; 2005 Apr; 38(4):499-507. PubMed ID: 15962175
[TBL] [Abstract][Full Text] [Related]
10. Perspectives for angiotensin profiling with liquid chromatography/mass spectrometry to evaluate ACE/ACE2 balance in endothelial dysfunction and vascular pathologies.
Olkowicz M; Chlopicki S; Smolenski RT
Pharmacol Rep; 2015 Aug; 67(4):778-85. PubMed ID: 26321281
[TBL] [Abstract][Full Text] [Related]
11. Physical Exercise and ACE2-Angiotensin-(1-7)-Mas Receptor Axis of the Renin Angiotensin System.
Nunes-Silva A; Rocha GC; Magalhaes DM; Vaz LN; Salviano de Faria MH; Simoes E Silva AC
Protein Pept Lett; 2017 Nov; 24(9):809-816. PubMed ID: 28758593
[TBL] [Abstract][Full Text] [Related]
12. Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases.
Parajuli N; Ramprasath T; Patel VB; Wang W; Putko B; Mori J; Oudit GY
Can J Physiol Pharmacol; 2014 Jul; 92(7):558-65. PubMed ID: 24861775
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
14. ACE inhibition, ACE2 and angiotensin-(1-7) axis in kidney and cardiac inflammation and fibrosis.
Simões E Silva AC; Teixeira MM
Pharmacol Res; 2016 May; 107():154-162. PubMed ID: 26995300
[TBL] [Abstract][Full Text] [Related]
15. ACE and ACE2 in inflammation: a tale of two enzymes.
Gaddam RR; Chambers S; Bhatia M
Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-(1-7): beyond the cardio-renal actions.
Passos-Silva DG; Verano-Braga T; Santos RA
Clin Sci (Lond); 2013 Apr; 124(7):443-56. PubMed ID: 23249272
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats.
Hamming I; van Goor H; Turner AJ; Rushworth CA; Michaud AA; Corvol P; Navis G
Exp Physiol; 2008 May; 93(5):631-8. PubMed ID: 18192334
[TBL] [Abstract][Full Text] [Related]
18. Role of ACE2 in diastolic and systolic heart failure.
Wang W; Bodiga S; Das SK; Lo J; Patel V; Oudit GY
Heart Fail Rev; 2012 Sep; 17(4-5):683-91. PubMed ID: 21638102
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo.
Echeverría-Rodríguez O; Del Valle-Mondragón L; Hong E
Peptides; 2014 Jan; 51():26-30. PubMed ID: 24184594
[TBL] [Abstract][Full Text] [Related]
20. Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme.
Agata J; Ura N; Yoshida H; Shinshi Y; Sasaki H; Hyakkoku M; Taniguchi S; Shimamoto K
Hypertens Res; 2006 Nov; 29(11):865-74. PubMed ID: 17345786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
